Glycogen Storage Disease Type I
Rare Disease·MeSH: Glycogen Storage Disease Type II
Prevalence
5.0 / 100K
7 drugs in development·4 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(4)
Phase 2(1)
| Drug | Company |
|---|---|
| alglucosidase alfa | Sanofi (SNY) |
Unknown(1)
| Drug | Company |
|---|---|
| alglucosidase alfa gz419829 | Sanofi (SNY) |
Phase 4(1)
| Drug | Company |
|---|---|
| avalglucosidase alfa | Sanofi (SNY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Glycogen Storage Disease Type I?
BioSniper tracks 7 drugs in development for Glycogen Storage Disease Type I across 4 companies.
How many clinical trials target Glycogen Storage Disease Type I?
There are 1 clinical trial targeting Glycogen Storage Disease Type I tracked by BioSniper.
What is the prevalence of Glycogen Storage Disease Type I?
The estimated prevalence of Glycogen Storage Disease Type I is approximately 5.0 per 100,000 population.
Deep-dive into Glycogen Storage Disease Type I
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis